Filipino-Born.
Globally Aligned.
Purpose-Driven.
As the Philippines’ leading CRO, PiVOT accelerates breakthrough treatments by delivering clinical trials with care, precision, and purpose.
Founded in 2018, PiVOT is the leading and largest Philippine Contract Research Organization (CRO). Our mission is to help develop life-changing treatments for Filipino patients from all walks of life and put the Philippines on the map for world-class clinical trials and impactful research.
The PiVOT
Difference
Local Expertise, Global Standards
ICH-GCP–trained teams with deep site relationships and regulatory fluency in the Philippines.
Dedicated, certified professionals
All CRAs are full-time and GCP-certified, ensuring consistency, compliance and accountability at every phase.
Focused on late-phase success
Proven delivery of Phase III and IV trials across oncology, infectious disease, and other high-impact areas.
Jose "Joval" Pantangco
President
Lizbeth Salonga
Associate Director, Clinical Operations
Earl Urbiztondo
Head of Finance
Sophia Perey
Business Development Manager
Edwin Perey
IT Manager
Company Milestones
2025
PiVOT leaders elected to the Philippine Clinical Research Professionals (PCRP) board of directors
2024
Joined ACRP
1st overseas FSP engagement
2023
Joined the Global Life Sciences Alliance (GLSA), a network of global CROs
1st DIA attendance (2022)
1st Pinnacle
2022
Complete 5 COVID-19 FDA applications, all approved
2021
Secured first COVID-19 PH FDA clinical trial approval
2020
Completed First FDA Clinical Trial Submissions and Approvals
2019
Started operations on
Pi Day (3.14)
2018
Incorporated as Pi Health Inc. and registered as a CRO with a License to Operate (LTO) by the Philippine Food and Drug Administration
2018
Incorporated as Pi Health Inc. and registered as a CRO with a License to Operate (LTO) by the Philippine Food and Drug Administration
2019
Started operations on
Pi Day (3.14)
2020
Completed First FDA Clinical Trial Submissions and Approvals
2021
Secured first COVID-19 PH FDA clinical trial approval
2022
Complete 5 COVID-19 FDA applications, all approved
2023
Joined the Global Life Sciences Alliance (GLSA), a network of global CROs
1st DIA attendance (2022)
1st Pinnacle
2024
Joined ACRP
1st overseas FSP engagement
2025
PiVOT leaders elected to the Philippine Clinical Research Professionals (PCRP) board of directors
